Artificial intelligence-based non-small cell lung cancer transcriptome RNA-sequence analysis technology selection guide by Min Soo Joo, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Jong-Moon Chung, Jong-Moon Chung, Byoung Chul Cho

Get full text

Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control by Kyoung-Ho Pyo, Kyoung-Ho Pyo, S. M. Mazidur Rahman, Diana Boraschi, Diana Boraschi, Diana Boraschi, Diana Boraschi

Get full text

Role and Function of O-GlcNAcylation in Cancer by Jii Bum Lee, Kyoung-Ho Pyo, Hye Ryun Kim

Get full text

Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types by Dong Kwon Kim, Dong Kwon Kim, Chai Young Lee, Yu Jin Han, So Young Park, Heekyung Han, Kwangmin Na, Mi Hyun Kim, Seung Min Yang, Sujeong Baek, Youngtaek Kim, Joon Yeon Hwang, Seul Lee, Seul Lee, Seong-san Kang, Min Hee Hong, Sun Min Lim, Jii Bum Lee, Jae Hwan Kim, Byoung Chul Cho, Byoung Chul Cho, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Kyoung-Ho Pyo

Get full text

CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production by Kwangmin Na, Seul Lee, Seul Lee, Dong Kwon Kim, Dong Kwon Kim, Young Seob Kim, Joon Yeon Hwang, Seong-san Kang, Sujeong Baek, Chai Young Lee, Seung Min Yang, Yu Jin Han, Mi hyun Kim, Heekyung Han, Youngtaek Kim, Jae Hwan Kim, Seunghyun Jeon, Youngseon Byeon, Jii Bum Lee, Sun Min Lim, Min Hee Hong, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Byoung Chul Cho, Byoung Chul Cho

Get full text

Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study by Beung-Chul Ahn, Jee Hung Kim, Kyoung-Ho Pyo, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Get full text

YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment by Dong Kwon Kim, Dong Kwon Kim, Chun-Bong Synn, Chun-Bong Synn, Seung Min Yang, Seongsan Kang, Sujeong Baek, Se-Woong Oh, Gyu-Jin Lee, Ho-Woong Kang, Young-Sung Lee, Jong Suk Park, Jae Hwan Kim, Youngseon Byeon, Young Seob Kim, Doo Jae Lee, Hyun-Woo Kim, June Dong Park, June Dong Park, Sung Sook Lee, Ji Yun Lee, Jii Bum Lee, Chang Gon Kim, Min Hee Hong, Sun Min Lim, Hey Ryun Kim, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Kyoung-Ho Pyo, Byoung Chul Cho, Byoung Chul Cho

Get full text

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treat... by Beung-Chul Ahn, Ji Hyun Lee, Min Hwan Kim, Kyoung-Ho Pyo, Choong-kun Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong

Get full text

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models by Sun Min Lim, San-Duk Yang, Sangbin Lim, Seong Gu Heo, Stetson Daniel, Aleksandra Markovets, Rafati Minoo, Kyoung-Ho Pyo, Mi Ran Yun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Get full text

Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease. by Bong-Kwang Jung, Kyoung-Ho Pyo, Ki Young Shin, Young Sang Hwang, Hyoungsub Lim, Sung Joong Lee, Jung-Ho Moon, Sang Hyung Lee, Yoo-Hun Suh, Jong-Yil Chai, Eun-Hee Shin

Get full text

363 Vactosertib and durvalumab as second or later line treatment for PD-L1 positive non-small cell lung cancer: interim result by Byoung Chul Cho, Jin Kyung Lee, Jiyeon Ryu, Bitna Oh, Sunjin Hwang, Ki Baik Hahm, Seong-Jin Kim, Ki Hyeong Lee, Ji-Youn Han, Byoung Yong Shim, Hye Ryun Kim, Kyoung-Ho Pyo, Jae-Hwan Kim, Chung-Feng Xin

Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing. by Seul Lee, Yunjoo Joo, Eun Ji Lee, Youngseon Byeon, Jae-Hwan Kim, Kyoung-Ho Pyo, Young Seob Kim, Sun Min Lim, Peter Kilbride, Rohin K Iyer, Mingming Li, Mandy C French, Jung-Yub Lee, Jeeheon Kang, Hyesin Byun, Byoung Chul Cho

Get full text

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity by Wongeun Lee, Wongeun Lee, Dong Kwon Kim, Chun-Bong Synn, Hee Kyu Lee, Sungho Park, Dong-Sik Jung, Yewon Choi, Jae Hwan Kim, Youngseon Byeon, Young Seob Kim, Seul Lee, Soyeon Lee, Yunjoo Joo, Eun Ji Lee, Mi Ran Yun, Seong Gu Heo, Wookyeom Yang, Ji Eun Jung, Eun Kyung Kim, Jooyeon Park, June Dong Park, June Dong Park, Doo Jae Lee, Hyeon-Woo Kim, Sun Min Lim, Min Hee Hong, Beung-Chul Ahn, Beung-Chul Ahn, Jii Bum Lee, Kyoung-Ho Pyo, Kyoung-Ho Pyo

Get full text

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma by Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, Hyeong -Seok Joo, Mi Ran Yun, Dongmin Jung, Jiyeon Yun, Seong Gu Heo, Beung -Chul Ahn, Chae Won Park, Kyoung Ho Pyo, You Jin Chun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Get full text

710 Keynote-B59: dose escalation of a phase 1/2 first-in-human, open-label study of GI-101, a novel immunocytokine combining CD80-IL2v, in combination with pembrolizumab in advance... by John Powderly, Jae Lyun Lee, Jung-Yun Lee, Byoung Chul Cho, Kyoung-Ho Pyo, Soohyeon Lee, Dong Kim, Myoung Ho Jang, Byoung Yong Shim, Sang Joon Shin, Nari Yun, Mina Ham, Julia Cohen, Hyo Jin Lee, Kyoyoung Lee, Hyunjin Kang, Jea Hwan Kim, Mi hyun Kim

Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies by Youngtaek Kim, Joon Yeon Hwang, Dong Kwon Kim, Kwangmin Na, Seul Lee, Sujeong Baek, Seong-san Kang, Seung Min Yang, Mi Hyun Kim, Heekyung Han, Chai Young Lee, Yu Jin Han, Min Hee Hong, Jii Bum Lee, Sun Min Lim, Byoung Chul Cho, Youngjoon Park, Kyoung-Ho Pyo

Get full text

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer by Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung‐Ho Pyo, Eun Joo Shin, Hyo Sup Shim, Ross A Soo, James Chih‐Hsin Yang, Sung Sook Lee, Hyun Chang, Min Hwan Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Get full text

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer by Han Na Kang, Jae-Hwan Kim, A-Young Park, Jae Woo Choi, Sun Min Lim, Jinna Kim, Eun Joo Shin, Min Hee Hong, Kyoung-Ho Pyo, Mi Ran Yun, Dong Hwi Kim, Hanna Lee, Sun Och Yoon, Da Hee Kim, Young Min Park, Hyung Kwon Byeon, Inkyung Jung, Soonmyung Paik, Yoon Woo Koh, Byoung Chul Cho, Hye Ryun Kim

Get full text

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models by Chun‐Bong Synn, Sung Eun Kim, Hee Kyu Lee, Min‐Hwan Kim, Jae Hwan Kim, Ji Min Lee, Ha Ni Jo, Wongeun Lee, Dong Kwon Kim, Youngseon Byeon, Young Seob Kim, Mi Ran Yun, Chae‐Won Park, Jiyeon Yun, Sangbin Lim, Seong Gu Heo, San‐Duk Yang, Eun Ji Lee, Seul Lee, Hunmi Choi, You Won Lee, Jae Seok Cho, Do Hee Kim, Sungho Park, Jung‐Ho Kim, Yewon Choi, Sung Sook Lee, Beung‐Chul Ahn, Chang Gon Kim, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Kyoung‐Ho Pyo, Byoung Chul Cho

Get full text